Allspring Global Investments Holdings, LLC Kodiak Sciences Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	BUY	$4.3 - $9.48 $94,217 - $207,716	21,911 New	21,911 $151,000
Q3 2022 Oct 26, 2022	BUY	$7.57 - $12.5 $118,788 - $196,150	15,692 New	15,692 $121,000
Q2 2022 Jul 25, 2022	SELL	$5.04 - $9.48 $2,726 - $5,128	-541 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$7.09 - $89.45 $22,539 - $284,361	-3,179 Reduced 85.46%	541 $4,000
Q4 2021 Jan 28, 2022	BUY	$80.85 - $128.49 $300,762 - $477,982	3,720 New	3,720 $315,000

Others Institutions Holding KOD

# of Institutions

Shares Held

39M

Call Options Held

6.5K

Put Options Held

5.8K

Baker Bros. Advisors LP New York, NY

17.3M
Shares

$151 Million
0.48% of portfolio
Black Rock Inc. New York, NY

3.85M
Shares

$33.7 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

1.95M
Shares

$17.1 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

1.69M
Shares

$14.7 Million
0.0% of portfolio
Iconiq Capital, LLC San Francisco, CA

1.02M
Shares

$8.9 Million
0.06% of portfolio

View Full List

About Kodiak Sciences Inc.

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $455M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

More about KOD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account